This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the benefits and harms of isoprinosine in the treatment of people with chronic HBV infection.
CITATION STYLE
Njei, B., Garg, S. K., Kenta-Bibi, E., Kongnyuy, E. J., & Alam, S. E. (2014). Isoprinosine for chronic hepatitis B. Cochrane Database of Systematic Reviews, 2014(3). https://doi.org/10.1002/14651858.CD011026
Mendeley helps you to discover research relevant for your work.